CurveBeam AI Ltd. engages in the research, design, and manufacture of cone beam computed tomography imaging systems. The company is headquartered in Hatfield, Pennsylvania. The company went IPO on 2023-08-23. Its products include HiRise, LineUp, PedCAT Premium, pedCAT, InReach, OssView, CubeVue Software, Autometrics, 3D Measurement Tools and Cloud. HiRise is a bilateral, weight-bearing CT imaging of the entire lower extremities including hips/pelvis and distal upper extremities. LineUP is a bilateral, weight bearing CT imaging of the distal lower extremities and distal upper extremities. InReach is a point-of-care extremity CT imaging for the upper extremities and the non-weight bearing lower extremities. InReach HR-pQCT is a high-resolution peripheral quantitative CT (HR-pQCT) imaging designed for the point-of-care. OssView is a bone fragility software that analyzes HR-pQCT images at the distal radius to measure the bone microarchitecture.
CRVAF 'in mevcut fiyatı $0.054 'dir, son işlem günde 0% azalmış etti.
Curvebeam AI Ltd için ana iş temaları veya sektörler nelerdir?
Curvebeam AI Ltd Health Care endüstrisine ait ve sektör Health Care 'dir
Curvebeam AI Ltd 'in piyasa değerlemesi nedir?
Curvebeam AI Ltd 'in mevcut piyasa değerlemesi $25.7M 'dir
Curvebeam AI Ltd al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 3 analist Curvebeam AI Ltd için analist derecelendirmeleri gerçekleştirdi, bunlar 1 güçlü al, 3 al, 1 tut, 0 sat ve 1 güçlü sat içermektedir